| Name | Title | Contact Details |
|---|
In a highly-commoditized world, the only differentiator is your story. To connect with your audience and empathize with their pain points, you need to craft your story through the lens of the customer. The team of strategists and storytellers at RAD can work with you to create an effective story that drives your marketing strategy. Every company has a story to tell, a reason as to why they are in business. We love taking that story and delivering it to where your customers are. River Avenue will put your story in front of your prospects and clients. riveravenuedigital.com/about-us.html
School District located in Cleveland, TX!
Foodservice Systems Inc is a Grafton, WI-based company in the Business Services sector.
Oculis (Nasdaq: OCS) is a global biopharmaceutical company purposefully driven to save sight and improve eye care. Oculis highly differentiated clinical-stage pipeline comprises multiple innovative product candidates in development for eye diseases of high unmet need. It includes OCS-01 eye drops, a topical candidate in Phase 3 development for diabetic macular edema (DME) and inflammation and pain following ocular surgery; OCS-02 eye drops, a topical biologic candidate in Phase 2 development for dry eye disease (DED) and uveitis; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophthalmic disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The first in-patient, proof-of-concept trial with OCS-05 is currently ongoing in France. Headquartered in Switzerland and with operations in the US, Europe, and China, Oculis goal is to deliver life-changing eye treatments to patients worldwide. The company is led by an experienced management team with a successful track record in the pharmaceutical industry, supported by leading international healthcare investors.